MPO and chronic kidney disease: Similarly, immunohistochemical staining for MPO-derived tyrosine modifications using specific antibodies for 3-chlorotyrosine and 3-nitrotyrosine demonstrated robust staining in the CKD-bMPOWT mice but not in the CKD-bMPOKO mice (Fig. S3).